Comments
Loading...

NovoCure

NVCRNASDAQ
Logo brought to you by Benzinga Data
$17.89
0.281.59%
Pre-Market: 4:01 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$200.00
Lowest Price Target1
$17.00
Consensus Price Target1
$64.91

NovoCure (NASDAQ:NVCR) Stock, Analyst Ratings, Price Targets, Forecasts

NovoCure Ltd has a consensus price target of $64.91 based on the ratings of 12 analysts. The high is $200 issued by Loop Capital on February 8, 2022. The low is $17 issued by JP Morgan on March 19, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, HC Wainwright & Co., and Evercore ISI Group on July 26, 2024, July 26, 2024, and July 2, 2024, respectively. With an average price target of $28 between Wells Fargo, HC Wainwright & Co., and Evercore ISI Group, there's an implied 56.51% upside for NovoCure Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
2
Apr
1
May
1
Jun
1
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
HC Wainwright & Co.
Evercore ISI Group
Piper Sandler
JP Morgan

1calculated from analyst ratings

Analyst Ratings for NovoCure

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for NovoCure (NVCR) stock?

A

The latest price target for NovoCure (NASDAQ:NVCR) was reported by Wells Fargo on July 26, 2024. The analyst firm set a price target for $40.00 expecting NVCR to rise to within 12 months (a possible 123.59% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for NovoCure (NVCR)?

A

The latest analyst rating for NovoCure (NASDAQ:NVCR) was provided by Wells Fargo, and NovoCure maintained their overweight rating.

Q

When was the last upgrade for NovoCure (NVCR)?

A

The last upgrade for NovoCure Ltd happened on August 8, 2023 when Piper Sandler raised their price target to $45. Piper Sandler previously had a neutral for NovoCure Ltd.

Q

When was the last downgrade for NovoCure (NVCR)?

A

The last downgrade for NovoCure Ltd happened on August 28, 2023 when HC Wainwright & Co. changed their price target from N/A to $25 for NovoCure Ltd.

Q

When is the next analyst rating going to be posted or updated for NovoCure (NVCR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NovoCure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NovoCure was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.

Q

Is the Analyst Rating NovoCure (NVCR) correct?

A

While ratings are subjective and will change, the latest NovoCure (NVCR) rating was a maintained with a price target of $42.00 to $40.00. The current price NovoCure (NVCR) is trading at is $17.89, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch